B. Chandrasekhar et al. / Tetrahedron 56 (2000) 5947±5952
5951
product was chromatographed over a column of neutral
alumina (100 g) (9:1 hexane/EtOAc) to obtain pure
g-lactam (4a±d) and xanthone (6a±d).
for C23H18ClNO3: C, 70.58; H, 4.60. Found: C, 70.12; H,
4.35.
Xanthone derivatives
2,4-Dihydro-8-methoxy-2-(4-methoxyphenyl)-4,4-dimethyl-
1H-[1]-benzopyrano[4,3,2-cd]-indol-1-one (4a). Using the
above procedure, O-alkylated 3a (1.51 g, 50 mmol) in acetic
acid (50 ml) and p-anisidine (0.65 g, 52 mmol) were
re¯uxed for 24 h. The crude mixture was puri®ed by column
chromatography (9:1 hexane/EtOAc) to afford 4a (0.97 g,
50%) as a light yellow solid, mp 206±2088. IR (KBr): 1700,
6-Methoxy-1[(4-methoxyphenyl)amino]-9H-xanthene-9-
one (6a). Using the above procedure, O-alkylated 3b
(1.37 g, 50 mmol) in acetic acid (50 ml) and p-anisidine
(0.65 g, 52 mmol) were re¯uxed for 18 h. The crude mixture
was puri®ed by column chromatography (9:1 hexane/
EtOAc) to afford 6a (0.52 g, 30%) as a light yellow solid,
mp 132±1348. IR (KBr): 3450±3300, 1630, 1600, 1450,
1
1590, 1450, 1250 cm21; H NMR (CDCl3): d 6.5±7.8 (m,
1
1260 cm21; H NMR: d 11.08 (s, 1H), 6.59±8.17 (m, 6H),
7H), 5.4 (s, 1H), 5.1 (s, 1H), 3.8 (s, 3H), 3.7 (s, 3H) 1.3 (s,
6H); 13C NMR (CDCl3) d 166.8, 160.6, 158.3, 155.3, 142.9,
132.9, 130.1, 127.5, 127.3, 124.7, 119.6, 114.4, 113.0,
111.8, 110.7, 108.3, 102.6, 55.4, 55.3, 41.6, 30.7; MS (EI)
m/z 387 (M1., 21), 372 (100), 359 (2), 329 (8), 301 (6), 286
(6), 258 (7), 238 (4). Anal. Calcd for C24H21NO4: C, 74.41;
H, 5.42. Found: C, 74.21; H, 5.36.
3.91 (s, 3H), 3.83 (s, 3H); 13C NMR (CDCl3): 179.4, 164.7,
158.0, 157.2, 156.9,150.3, 135.0, 133.1, 115.8, 114.7, 112.7,
107.0, 105.5, 103.5, 99.7, 55.7, 55.4; MS (EI): m/z 347 (M1,
97.5), 332 (100), 319 (2), 317 (6), 316 (5), 289 (21), 288
(22), 261 (5), 232 (2); Anal. Calcd for C21H17NO4: C, 72.62,
H, 4.89. Found: C, 72.41; H, 4.72.
2,4-Dihydro-8-methoxy-4,4-dimethyl-2-(4-methylphenyl)-
1H-[1]benzopyrano[4,3,2-cd]-indol-1-one (4b). Using the
above procedure, O-alkylated 3a (1.51 g, 50 mmol) in acetic
acid (50 ml) and p-toluidine (0.55 g, 52 mmol) were
re¯uxed for 24 h. The crude mixture was puri®ed by column
chromatography (9:1 hexane/EtOAc) to afford 4b (0.89 g,
48%) as a light yellow solid, mp 172±1748. IR (KBr): 1700,
6-Methoxy-1-[(4-methylphenyl)amino]-9H-xanthene-9-
one (6b). Using the above procedure, O-alkylated 3b
(1.37 g, 50 mmol) in acetic acid (50 ml) and p-toluidine
(0.55 g, 52 mmol) were re¯uxed for 18 h. The crude mixture
was puri®ed by column chromatography (9:1 hexane/
EtOAc) to afford 6b (0.46 g, 28%) as a light yellow solid,
mp 116±1188. IR (KBr): 1630, 1600, 1580, 1440, 1270,
1
1620, 1450, 1240 cm21; H NMR: d 6.54±7.80 (m, 7H),
1
1160 cm21; H NMR: d 10.4 (s, 1H), 6.61±8.18 (m, 10H),
3.93 (s, 3H), 2.36 (s, 3H); MS (EI) m/z 331 (M1, 100), 314
(3), 288 (1), 279 (5); Anal. Calcd for C21H17NO3: C, 76.13;
H, 5.13. Found: C, 75.89; H, 5.0.
5.56 (s, 1H), 5.17 (s, 1H), 3.79 (s, 3H), 2.39 (s, 3H), 1.29
(s, 6H); 13C NMR (CDCl3): d 166.7, 160.7, 155.3, 143.0,
136.7, 132.6, 132.3, 124.8, 119.8, 113.1, 111.8, 110.7,
108.4, 102.7, 55.4, 30.1, 21.1; MS (EI) m/z 371 (M1, 24),
356 (100), 327 (4), 313 (10), 284 (4); Anal. Calcd for
C24H21NO3, C, 77.62; H, 5.66. Found: C, 77.24; H, 5.35.
6-Methoxy-1-[(phenyl)amino]-9H-xanthen-9-one (6c).
Using the above procedure, O-alkylated 3b (1.37 g,
50 mmol) in acetic acid (50 ml) and freshly distilled aniline
(0.48 g, 52 mmol) were re¯uxed for 18 h. The crude mixture
was puri®ed by column chromatography (9:1 hexane/
EtOAc) to afford 6c (0.40 g, 25%) as a pale yellow solid,
mp 140±1428. IR (KBr): 1640, 1600, 1400, 1270 cm21; 1H
NMR: d 10.8 (s, 1H), 6.32±7.92 (m, 10H), 3.85 (s, 3H), MS
(EI) m/z 317 (M1, 100), 316 (22), 300 (22), 274 (8), 257
(12), 167 (11); Anal. Calcd for C20H15NO3: C, 75.7; H, 4.73.
Found: C, 75.52; H, 4.51.
2,4-Dihydro-8-methoxy-4,4-dimethyl-2-phenyl-1H-[1]-
benzopyrano[4,3,2-cd]-indol-1-one (4c). Using the above
procedure, O-alkylated 3a (1.51 g, 50 mmol) in acetic acid
(50 ml) and freshly distilled aniline (0.48 g, 52 mmol) were
re¯uxed for 24 h. The crude mixture was puri®ed by column
chromatography (9:1 hexane/EtOAc) to afford 4c (0.78 g,
45%) as a light yellow solid, mp 182±1848. IR (KBr): 1700,
1620, 1240 cm21; 1H NMR (CDCl3): d 6.5±7.8 (m, 8H), 5.6
(s, 1H), 5.2 (s, 1H), 3.8 (s, 3H), 1.3 (s, 6H); 13C NMR
(CDCl3): d 166.5, 160.7, 155.2, 142.9, 135.0, 132.4,
130.3, 129.1, 126.8, 125.8, 124.7, 119.0, 113.0, 111.9,
110.6, 55.4, 41.7, 30.1; MS (EI) m/z 357 (M1, 22), 342
(100), 299 (6), 270 (4); Anal. Calcd for C23H19NO3; C,
77.31; H, 5.32. Found: C, 77.18; H, 5.08.
6-Methoxy-1[(4-chlorophenyl)amino]-9H-xanthen-9-one
(6d). Using the above procedure, O-alkylated 3b (1.37 g,
50 mmol) in acetic acid (50 ml) and p-chloroaniline
(0.66 g, 52 mmol) were re¯uxed for 18 h. The crude mixture
was puri®ed by column chromatography (9:1 hexane/
EtOAc) to afford 6d (0.35 g, 20%) as a lemon yellow
solid, mp 158±1608. IR (KBr): 1640, 1600, 1400,
2-(4-Chlorophenyl)-2,4-dihydro-8-methoxy-4,4-dimethyl-
1H-[1]benzopyrano[4,3,2-cd]-indol-1-one (4d). Using the
above procedure, O-alkylated 3a (1.51 g, 50 mmol) in acetic
acid (50 ml) and p-chloroaniline (0.66 g, 52 mmol) were
re¯uxed for 24 h. The crude mixture was puri®ed by column
chromatography (9:1 hexane/EtOAc) to afford 4d (0.78 g,
40%) as a lemon-yellow solid, mp 202±2048. IR (KBr):
1
1270 cm21; H NMR: d 10.8 (s, 1H), 6.32±7.92 (m, 10H),
3.85 (s, 3H). MS (EI): m/z 351 (M1, 100), 350 (14), 334
(18), 315 (10), 308 (4), 273 (10), 263 (22); Anal. Calcd for
C20H14ClNO3: C, 68.37; H, 3.98. Found: C, 68.15; H, 3.75.
6-Methoxy-3-methyl-1-[(4-methoxyphenyl)amino]-9H-
xanthen-9-one (7a). Using the above procedure, O-alkyl-
ated 3c (1.44 g, 50 mmol) in acetic acid (50 ml) and p-anisi-
dine (0.65 g, 52 mmol) were re¯uxed for 18 h. The crude
mixture was puri®ed by column chromatography (9:1 hex-
ane/EtOAc) to afford 7a (0.36 g, 20%) as a pale yellow
solid, mp 145±1468. IR (KBr): 1630, 1600, 1400,
1
1700, 1600, 1420, 1240 cm21; H NMR (CDCl3): d 6.6±
7.8 (m, 7H), 5.6 (s, 1H), 5.2 (s, 1H), 3.8 (s, 3H), 1.3 (s, 6H);
13C NMR (CDCl3): 166.4, 160.7, 155.2, 142.9, 133.5, 132.3,
132.1, 130.5,129.3, 127.0, 124.7, 120.0, 113.0, 112.1,
110.4, 108.4, 102.7, 55.4, 41.7, 30.1; MS (EI) m/z 391
(M1, 12), 376 (100), 333 (14), 270 (8), 240 (4); Anal. Calcd